imirestat has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eaton, JW; Hunt, JV; Jiang, ZY; Koppenol, WH; Wolff, SP; Zhou, QL | 1 |
| Blouin, RA; Brazzell, RK; McNamara, PJ | 1 |
2 other study(ies) available for imirestat and Diabetes Mellitus
| Article | Year |
|---|---|
Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro.
Topics: Aldehyde Reductase; Antioxidants; Ascorbic Acid; Copper; Diabetes Mellitus; Dose-Response Relationship, Drug; Fluorenes; Humans; Hydantoins; Imidazoles; Imidazolidines; Iron; Oxidation-Reduction; Structure-Activity Relationship | 1991 |
The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
Topics: Adult; Aldehyde Reductase; Animals; Blood Glucose; Blood Proteins; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diazepam; Fluorenes; Humans; Hydantoins; Male; Phenytoin; Propranolol; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Sugar Alcohol Dehydrogenases | 1988 |